We are live on ! Find out more
IMGO

Imago BioSciences, Inc. Common stock
IMGO

Delisted

IMGO was delisted on the 10th of January, 2023.

Back to rankings

0 hedge funds and large institutions have $0 invested in Imago BioSciences, Inc. Common stock in 2023 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 105 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 106 → 0 (-106)

100% less funds holding in top 10

Funds holding in top 10: 5 → 0 (-5)

100% less capital invested

Capital invested by funds: $1.05B → $0 (-$1.05B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 105

Holders
–
Holders Change
-106
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
-5
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
105
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$161M
2
FLSM
Frazier Life Sciences Management
California
-$143M
3
OFM
Omega Fund Management
Massachusetts
-$109M
4
Blackstone Inc
Blackstone Inc
New York
-$85.4M
5
Vanguard Group
Vanguard Group
Pennsylvania
-$45.5M
Name Holding Trade Value Shares
Change 		Change in
Stake
E
26
Ergoteles
New York
– -$8.46M -235,442 Closed
WIC
27
Water Island Capital
New York
– -$8.4M -233,522 Closed
Qube Research & Technologies (QRT)
28
Qube Research & Technologies (QRT)
United Kingdom
– -$8.39M -233,481 Closed
Adage Capital Partners
29
Adage Capital Partners
Massachusetts
– -$8.09M -225,000 Closed
UBS Group
30
UBS Group
Switzerland
– -$6.71M -186,545 Closed
GCIA
31
Gabelli & Co Investment Advisers
New York
– -$6.06M -168,600 Closed
PCM
32
Prelude Capital Management
New York
– -$6.02M -167,339 Closed
Millennium Management
33
Millennium Management
New York
– -$4.59M -127,773 Closed
AllianceBernstein
34
AllianceBernstein
Tennessee
– -$4.48M -124,657 Closed
Fidelity International
35
Fidelity International
Bermuda
– -$4.31M -120,000 Closed
SCM
36
Soleus Capital Management
Connecticut
– -$4.13M -115,000 Closed
Bank of New York Mellon
37
Bank of New York Mellon
New York
– -$3.6M -100,126 Closed
N
38
Nuveen
North Carolina
– -$3.51M -97,546 Closed
Citadel Advisors
39
Citadel Advisors
Florida
– -$3.5M -97,340 Closed
CS
40
Credit Suisse
Switzerland
– -$3.1M -86,174 Closed
KC
41
Kellner Capital
New York
– -$2.96M -82,200 Closed
Renaissance Technologies
42
Renaissance Technologies
New York
– -$2.92M -81,300 Closed
Charles Schwab
43
Charles Schwab
California
– -$2.52M -69,966 Closed
Bank of America
44
Bank of America
North Carolina
– -$2.22M -61,666 Closed
FSI
45
Flow State Investments
Illinois
– -$2M -55,512 Closed
SAM
46
Silphium Asset Management
United Kingdom
– -$1.8M -50,000 Closed
CS
47
Candriam SCA
Luxembourg
– -$1.73M -48,094 Closed
GI
48
GAMCO Investors
Connecticut
– -$1.66M -46,169 Closed
WAM
49
Wolverine Asset Management
Illinois
– -$1.65M -45,958 Closed
KCM
50
Kennedy Capital Management
Missouri
– -$1.64M -45,756 Closed
1
2
3 4 5

IMGO Hedge Fund Activity: Q1 2023 in Review

0 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Imago BioSciences, Inc. Common stock (IMGO) for Q1 2023, worth a combined $0 — down 100% from $1.05B a quarter earlier.

Sellers outnumbered buyers: 105 funds closed out of IMGO and 0 opened new positions — a net loss of 105 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was BlackRock, exiting entirely with an estimated $161M sold.

  • 0 institutional investors held Imago BioSciences, Inc. Common stock (IMGO) as of Q1 2023, down from 106 in Q4 2022.
  • Funds reported $0 of Imago BioSciences, Inc. Common stock stock for Q1 2023, down 100% quarter-over-quarter.
  • 0 funds opened new Imago BioSciences, Inc. Common stock positions in Q1 2023 and 105 closed out, a net change of -105 holders.
  • The largest Imago BioSciences, Inc. Common stock seller in Q1 2023 was BlackRock, an estimated $161M sold.

Based on aggregated 13F filings for Q1 2023.